lemme glp-1 37399915_web1_M1-FWM20240917-Lemme-GLP-1-Daily–Teaser The Problem With the Lemme
Description
Cardiovascular, mortality, and kidney outcomes with GLP1 receptor agonists in patients with type 2 diabetes: a systematic review and metaanalysis of randomised trials
:quality(85):upscale()/2024/09/19/783/n/49351082/2c557c9c66ec63d36577f4.31206634_.jpg)
Diabetologia 61(11):23102318
Additionally, given that the CPRD is a general practice database, prescriptions written by specialists are not captured, which may be another source of exposure misclassification
Mike Haney: When you talk about stopping the medications, what do you think about the concept of metabolic whiplash
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Therefore, impaired autophagy may contribute to the AD pathogenesis (73)
